Search Results - "Sarah Bétrian"

Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer by Martinez, Alejandra, Chantalat, Elodie, Angeles, Martina Aida, Ferron, Gwénaël, Ducassou, Anne, Daix, Manon, Attal, Justine, Bétrian, Sarah, Lusque, Amélie, Gabiache, Erwan

“…Background To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph…”
Get full text

The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer by Angeles, Martina Aida, Hernández, Alicia, Pérez-Benavente, Asunción, Cabarrou, Bastien, Spagnolo, Emanuela, Rychlik, Agnieszka, Daboussi, Amel, Migliorelli, Federico, Bétrian, Sarah, Ferron, Gwénaël, Gil-Moreno, Antonio, Guyon, Frédéric, Martinez, Alejandra

“…To assess the impact on survival of major postoperative complications and to identify the factors associated with these complications in patients with advanced…”
Get full text

Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer by Angeles, Martina Aida, Migliorelli, Federico, Del, Mathilde, Martínez-Gómez, Carlos, Daix, Manon, Bétrian, Sarah, Gabiache, Erwan, Balagué, Gisèle, Leclerc, Sophie, Mery, Eliane, Gladieff, Laurence, Ferron, Gwénaël, Martinez, Alejandra

“…Purpose The aim of our study was to assess concordance of staging laparoscopy and cytoreductive surgery (CRS) peritoneal cancer index (PCI) when applying a…”
Get full text

Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer by Angeles, Martina Aida, Cabarrou, Bastien, Gil-Moreno, Antonio, Pérez-Benavente, Asunción, Spagnolo, Emanuela, Rychlik, Agnieszka, Martínez-Gómez, Carlos, Guyon, Frédéric, Zapardiel, Ignacio, Querleu, Denis, Illac, Claire, Migliorelli, Federico, Bétrian, Sarah, Ferron, Gwénaël, Hernández, Alicia, Martinez, Alejandra

“…We sought to evaluate the impact on survival of tumor burden and surgical complexity in relation to the number of cycles of neoadjuvant chemotherapy (NACT) in…”
Get full text

Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia by Bétrian, Sarah, Guenounou, Sarah, Luquet, Isabelle, Demur, Cécile, Huynh, Anne, Ysebaert, Loïc, Recher, Christian, Huguet, Françoise

“…Optimal treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare entity of dismal prognosis previously described as CD4+/CD56+ hematodermic…”
Get full text

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's) by Bétrian, Sarah, Bergeron, Christophe, Blay, Jean-Yves, Bompas, Emmanuelle, Cassier, Philippe A, Chevallier, Laure, Fayette, Jérome, Girodet, Magali, Guillemet, Cécile, Le Cesne, Axel, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine

“…Desmoplastic small round cell tumor (DSRCT) is a very rare mesenchymal tumor that mainly affects teenagers and young adults with a mean age at diagnosis around…”
Get full text

Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer by Martina Aida Angeles, Bastien Cabarrou, Antonio Gil-moreno, Asunción Pérez-benavente, Emanuela Spagnolo, Agnieszka Rychlik, Carlos Martínez-gómez, Frédéric Guyon, Ignacio Zapardiel, Denis Querleu, Claire Illac, Federico Migliorelli, Sarah Bétrian, Gwénaël Ferron, Alicia Hernández, Alejandra Martinez

“…Objective: We sought to evaluate the impact on survival of tumor burden and surgical complexity in relation to the number of cycles of neoadjuvant chemotherapy…”
Get full text

Basics of immunotherapy for epithelial ovarian cancer by Bund, Virginie, Azaïs, Henri, Bibi-Triki, Sabrina, Lecointre, Lise, Betrian, Sarah Bétrian, Angeles, Martina Aida, Eberst, Lauriane, Faller, Emilie, Boisramé, Thomas, Bendifallah, Sofiane, Akladios, Chérif, Deluche, Élise

“…Epithelial ovarian cancer (EOC) is the most lethal of all gynecological cancers. Despite excellent responses to standard treatment in approximately 70% of…”
Get full text

ODALIE Study, a retrospective analysis of a real-life cohort of patients with de novo advanced high grade epithelial ovarian cancer treated with a first-line platinum- and taxane-based chemotherapy combined with bevacizumab by Bétrian, Sarah Lagarde, Penault Llorca, Frederique, Pautier, Patricia, Joly, Florence, Ray-Coquard, Isabelle Laure, Costaz, Hélène, Sauterey, Baptiste, Floquet, Anne, De La Motte Rouge, Thibault, Gourgou, Sophie, Marchal, Frédéric, Guillemet, Cecile, Petit, Thierry, Rouzier, Roman, Simon, Gaetane, Gladieff, Laurence

“…e17577 Background: PARP inhibitors (PARPi) demonstrated improvement in progression-free survival (PFS) following a first line platinum-based chemotherapy…”
Get full text

In situ immune impact of nivolumab + ipilimumab combination before standard chemoradiation therapy (RTCT) for FIGO IB3-IVA in patients (pts) with cervical squamous carcinoma: COLIBRI trial, a GINECO study by Ray-Coquard, Isabelle Laure, Kaminsky-Forrett, Marie-Christine, Ohkuma, Ryotaro, De Montfort, Aymeric, Joly, Florence, Treilleux, Isabelle, Ghamry-Barrin, Sarah, Bello-Roufai, Diana, Saintigny, Pierre, Angelergues, Antoine, Michon, Lucas, Hardy-Bessard, Anne-Claire, Lainé, Alexandra, Savoye, Aude-Marie, Berthet, Justine, Caux, Christophe, Lecuru, Fabrice, Dubois, Bertrand, Lagarde Bétrian, Sarah

“…5501 Background: We report the results of a window-of-opportunity phase 2 trial using neoadjuvant nivolumab + ipilimumab followed by standard chemoradiation…”
Get full text

Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors by Bétrian, Sarah, Gomez-Roca, Carlos, Vigarios, Emmanuelle, Delord, Jean Pierre, Sibaud, Vincent

Get more information

Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report by Laurenty, Anne-Pascale, Thomas, Fabienne, Chatelut, Etienne, Bétrian, Sarah, Le Guellec, Chantal, Hennebelle, Isabelle, Le Guellec, Sophie, Chevreau, Christine

“…We describe here the case of a 60-year old male patient treated for an extensive local progression of a pleiomorphic sarcoma on the right tibial crest with…”
Get more information

Retour de congrès Atelier international sur la leucémie lymphoïde chronique (IWCLL) 2015, Sydney by Bétrian, Sarah, Dumont, Anne, Protin, Caroline

Get full text

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer by Leboulleux, Sophie, Do Cao, Christine, Zerdoud, Slimane, Attard, Marie, Bournaud, Claire, Lacroix, Ludovic, Benisvy, Danielle, Taïeb, David, Bardet, Stéphane, Terroir-Cassou-Mounat, Marie, Anizan, Nadège, Bouvier-Morel, Emilie, Lamartina, Livia, Lion, Georges, Betrian, Sarah, Sajous, Christophe, Schiazza, Aurélie, Garcia, Marie-Eve, Ciappuccini, Renaud, Schlumberger, Martin, Al Ghuzlan, Abir, Godbert, Yann, Borget, Isabelle

“…To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer…”
Get full text

Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center by Al Darazi, Ghassan, Martin, Elodie, Delord, Jean‐Pierre, Korakis, Iphigenia, Betrian, Sarah, Estrabaut, Myriam, Poublanc, Muriel, Gomez‐Roca, Carlos, Filleron, Thomas

“…We compared the performance of six prognostic scores (Royal Marsden Hospital, MDACC: MD Anderson Clinical Center and MDACC + NLR: neutrophil‐to‐lymphocyte…”
Get full text

Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending by Ortiz Brugués, Ariadna, Sibaud, Vincent, Herbault‐Barrés, Beatrice, Betrian, Sarah, Korakis, Iphigenie, De Bataille, Caroline, Gomez‐Roca, Carlos, Epstein, Joel, Vigarios, Emmanuelle

“…Commenting on a recently published article on sicca syndrome linked to immune checkpoint inhibitor therapy, this letter to the editor shares another viewpoint…”
Get full text

MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131 I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer by Leboulleux, Sophie, Do Cao, Christine, Zerdoud, Slimane, Attard, Marie, Bournaud, Claire, Lacroix, Ludovic, Benisvy, Danielle, Taïeb, David, Bardet, Stéphane, Terroir-Cassou-Mounat, Marie, Anizan, Nadège, Bouvier-Morel, Emilie, Lamartina, Livia, Lion, Georges, Betrian, Sarah, Sajous, Christophe, Schiazza, Aurélie, Garcia, Marie-Eve, Ciappuccini, Renaud, Schlumberger, Martin, Al Ghuzlan, Abir, Godbert, Yann, Borget, Isabelle

“…Abstract Purpose: To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic…”
Get full text

First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors by Elez, Elena, Gomez-Roca, Carlos, Soto Matos-Pita, Arturo, Argiles, Guillem, Valentin, Thibaud, Coronado, Cinthya, Iglesias, Jorge, Macarulla, Teresa, Betrian, Sarah, Fudio, Salvador, Zaragoza, Katrin, Tabernero, Josep, Delord, Jean-Pierre

“…Summary Background Plocabulin (PM060184) is a novel marine-derived microtubule inhibitor that acts as an antitumor agent. This first-in-human study evaluated…”
Get full text

5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC) by Sarradin, Victor, Betrian, Sarah, Chaltiel, Léonor, Brac De La Perriere, Clémence, Delord, Jean Pierre

“…Sinonasal intestinal-type adenocarcinoma (ITAC) is a rare tumor, typically found in the ethmoid or upper nasal cavity. There is no standard systemic treatment…”
Get full text

Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer by Angeles, Martina Aida, Spagnolo, Emanuela, Cabarrou, Bastien, Pérez-Benavente, Assumpció, Gil Moreno, Antonio, Guyon, Frederic, Rychlik, Agnieszka, Migliorelli, Federico, Bataillon, Guillaume, Navarro, Anne-Sophie, Betrian, Sarah, Ferron, Gwenael, Hernández, Alicia, Martinez, Alejandra

“…Our study aimed to evaluate the association between timing of cytoreductive surgery and pattern of presentation of the first recurrence in patients with…”
Get more information